News for hackers. Stuff that matters.
Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by kneel on Wednesday February 15, 2017 @10:27PM (#13657595)
UC Berkeley's Doudna should be livid.

She worked on this technology for years, developing it from it's infancy to in vitro proof. MIT scientists swooped in and within 2 months applied it in-vivo and patented it.

I guess to be rewarded in science you have to be a master in your field and intensely concerned with IP deadlines.

It's really a shame that Berkeley loses licensing on a tech that was 95% developed at Berkeley.

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by acomjean on Wednesday February 15, 2017 @11:05PM (#13657685)
I'm one of those who wonder if these things should be patented. That being said:

"Swoop in and patented it" is not exactly how it goes. There is a long back story to this with a lot of people discoing stuff to make this possible.[1]

CRISPR-CAS9 will probably be supplanted by something else. They're already working on it (hopefully with fewer off target effects). http://www.nature.com/news/alternative-crispr-system-could-i...

You can watch a video by Zheng (the patent holder) on how CRISPR works if you are curious[2]

I doubt she's livid, they won a lot of research prize money from their research [2] and she's probably collect money from patents from the company she started with the patent holder "Editas Medicine. Co-founded by the Broad’s Zhang (and also by Doudna, in more collegial days)"[2]

as with most patent disputes the lawyers are the real winners: "The Broad’s legal costs, paid by Editas, topped $15 million last summer. UC’s, paid by Caribou, have passed $5 million. Neither party has said what they have spent since then."[2]

[1]http://www.cell.com/cell/fulltext/S0092-8674(15)01705-5

[2]https://www.statnews.com/2017/02/15/crispr-patent-ruling/

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by kneel on Wednesday February 15, 2017 @11:26PM (#13657759)
I would definitely take that cell review with a grain of salt seeing as it was written by MIT/Broad institute.
Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by acomjean on Wednesday February 15, 2017 @11:40PM (#13657805)
Why? It has a lot of interesting history of the discovery of CRISPR which is really interesting..
Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by tedsanders on Wednesday February 15, 2017 @11:49PM (#13657825)
The article, written by Eric Lander of the Broad Institute, was widely criticized[1][2][...] at its publication for being a veiled attempt to reframe history to support the Broad Institute's patent claims. Note a number of their framing decisions - choosing to group Doudna et. al.'s contributions as #4 in a long list and setting Zheng's contribution by itself in a different color. Seems innocuous when skimming over it, but the choice of what to emphasize and categorize is not objectively deterministic, and this particular framing and coloring was no doubt chosen deliberately. Many think there was purposeful deception behind that deliberate choice.

[1] http://genotopia.scienceblog.com/573/a-whig-history-of-crisp...

[2] http://www.michaeleisen.org/blog/?p=1825

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by acomjean on Thursday February 16, 2017 @12:16AM (#13657903)
interesting.

I don't really have a horse in this race, but I am new to working in the Biology field. I will say that biology seems to depend on the work of many people and is kind of incremental. Its weird that some are getting rich and lots of credit, while a lot of the researchers work in obscurity. That was my take away from the Cell article.

Your first article was a good critique of the Cell article.

The second one was a little hard to take seriously first[1] (plus written by someone from the other side of the dispute), though he does come around to my original point in my original post: "And, as I have long argued, I believe that neither Berkeley nor MIT should have patents on CRISPR, since it is a disservice to science and the public for academic scientists to ever claim intellectual property in their work."

[1]"Lander’s recent essay in Cell entitled “The Heroes of CRISPR” is his masterwork, at once so evil and yet so brilliant that I find it hard not to stand in awe even as I picture him cackling loudly in his Kendall Square lair, giant laser weapon behind him poised to destroy Berkeley if we don’t hand over our patents."

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by abecedarius on Thursday February 16, 2017 @01:26AM (#13658106)
"The work of many people" is literally the title of a paper by Edward Teller that in some opinions had the same kind of aim as we're talking about here for the Lander paper -- minimizing Ulam's contribution to the Ulam-Teller mechanism behind the H-bomb. (I can't tell if that's fair, not least because only the first page is accessible: http://science.sciencemag.org/content/121/3139/267 Background: https://en.wikipedia.org/wiki/History_of_the_Teller%E2%80%93...)

I was reminded of it when Lander's article came out, not just now.

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by linuxkerneldev on Thursday February 16, 2017 @03:25AM (#13658438)
> topped $15 million last summer. UC’s, paid by Caribou, have passed $5 million.

So a $20 million boon for lawyers and who knows how many hours the researchers lost being distracted by legal issues. One wonders how we could rework our legal system so that that kind of funds and that kind of time don't get wasted like this and instead reward both the researchers and the implementers that get it into practically usable form.

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by bayesian_horse on Thursday February 16, 2017 @04:14AM (#13658606)
The money the lawyers made may be nothing compared to the royalties.
Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by CalChris on Wednesday February 15, 2017 @11:35PM (#13657781)
In my opinion, an opinion, the Berkeley IP office is a pain and thus its own enemy. They could take a lesson from Stanford and be more of a partner and advocate for faculty and students. They lost Howe (EE105) to Stanford over simply being a pain rather than a resource.
Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by dekhn on Thursday February 16, 2017 @09:09AM (#13659936)
Damn straight- Berkeley's IP office is absolutely impossible to deal with. They value their property infinitely high.
Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by CalChris on Thursday February 16, 2017 @10:47AM (#13660805)
They also value their prerogatives infinitely high which makes them a pain internally. Outside of the BSD case, I'm struggling to think of anything they've done right.
Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by amelius on Thursday February 16, 2017 @07:44AM (#13659449)
I'm strongly against patents in science.

Science = standing on the shoulders of others. It is not fair if the one (momentarily) standing on top receives all the benefits.

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by eumoria on Thursday February 16, 2017 @08:26AM (#13659690)
particularly when a lot of the research was achieved by charity funding and tax grants. public funded then privately profited is a disgusting outcome of our current research system.
Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by refurb on Thursday February 16, 2017 @08:53AM (#13659836)
I would disagree. Securing a patent means that further investment is possible.

Yes, one of the two labs discovered CRISPR. OK, now what? It's not a treatment at this point, it's just a technique. So someone has to invest a ton of money to turn the technique into a therapy for humans. And I would bet that investment will absolutely dwarf what's been spent so far.

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by amelius on Thursday February 16, 2017 @09:34AM (#13660099)
This means that only one line of further development will be possible, since a patent is basically a license for a monopoly.

Instead, we could grant subsidies and have multiple developments working in parallel.

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by refurb on Thursday February 16, 2017 @10:17AM (#13660481)
Depending on what the other uses are, the patent holder is always able to out-license the patent for specific uses. This is actually pretty common in biotech.
Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by whitenoice on Wednesday February 15, 2017 @10:35PM (#13657607)
Interested to know what other licenses Berkeley lost, can you state few notable ones?
Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by onewaystreet on Wednesday February 15, 2017 @10:56PM (#13657663)
> I guess to be rewarded in science you have to be a master in your field and intensely concerned with IP deadlines.

Dr. Zhang and MIT proved that the Crispr technique would work in plant, animal and human cells. The value of the patents is in that research, not Doudna's in vitro proof.

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by kneel on Wednesday February 15, 2017 @11:02PM (#13657672)
Doudna took Cripsr from an odd genomic pattern to proof of Cripr/Cas9 being a bacterial immunity complex complete with proof of mechanism.

Transferring that body of work over to in-vivo is trivial in comparison to what she did. Transferring genes from one organism to another is run of the mill molecular biology.

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by Q6T46nT668w6i3m on Wednesday February 15, 2017 @11:22PM (#13657747)
Transferring that body of work over to in-vivo is trivial in comparison to what she did. Transferring genes from one organism to another is run of the mill molecular biology.

Nobody, including Doudna, would agree with this.

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by kneel on Wednesday February 15, 2017 @11:29PM (#13657768)
Absolutely false.

This tech has been around for years. Monsanto wouldn't exist without molecular biology. We'd still be extracting insulin out of farm animals if molecular biology hadn't allowed scientists to grow it in yeast.

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by estsauver on Thursday February 16, 2017 @01:27AM (#13658109)
You're mistaking traditional cell bio libraries with CRISPR, crispr takes a two year process and makes it two weeks. It's really quite a significant change.

The tech is really not the same, it's the difference between hand braided core-ram and re programmable memory. It's a huge difference.

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by shirakawasuna on Thursday February 16, 2017 @02:27AM (#13658265)
The process of putting the CRISPR genes in a cell and making them target a given gene is trivially simple and undergraduates around the world are doing it every hour (if not more). The Broad group did a little more than that, but it's nothing compared to UC's group's pioneering effort, and amounts mostly to breaking a certain part of the functionality and doing some very standard tests.

The tool is extremely effective, as you say, and was primarily "designed" via natural selection. The researchers (1) discovered it, teased out its mechanism of action, and its programmability, and (2) did standard molecular bio techniques to show that it works across several oragnisms.

This ruling is based on the fact that the original inventors didn't throw the genes into cells, publish, and (most importantly) apply for patents before the Broad group did. Whether it would work in those other cells was a crapshoot and doesn't represent any significant creative work, and a minor work of science. The importance is the result - we know it works in those cells.

Source: I also work in this field. This ruling is absurd.

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by daemonk on Thursday February 16, 2017 @07:13AM (#13659288)
Doudna definitely deserves all the credit for clarifying the mechanism and modifying the system for sgRNA instead of the original two RNAs.

But what Zhang did was not trivial. He did not just take Doudna's system and threw it into a mammalian system. He modified the system so: 1) codon optimized (not very hard, I know). 2) Added two localization signal sequences so it goes into the nucleus. 3) And most importantly, he modified the system (nuclease to nickase) so mismatch repair (homology based repair) occurs more frequently than non-homologous end joining. These modifications are not trivial and probably took a lot of trial and error.

Just because crispr is so simple to perform now doesn't mean there wasn't a lot of effort on both Doudna and Zhang's part.

Personally, I believe both of them should have been on the patent. For me, Doudna came up with the Ford model T and Zhang iterated and extended it into a Ferrari.

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by libeclipse on Wednesday February 15, 2017 @11:18PM (#13657730)
What are your credentials?
Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by kneel on Wednesday February 15, 2017 @11:31PM (#13657770)
I work in the field. Very familiar with Crispr/Cas9
Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by onewaystreet on Wednesday February 15, 2017 @11:07PM (#13657691)
> Transferring that body of work over to in-vivo is trivial in comparison to what she did.

If this was the case then she would have won the patent fight. The Patent Trial and Appeal Board thought otherwise. Did you read their 51-page decision?

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by johncolanduoni on Thursday February 16, 2017 @12:02AM (#13657860)
Just world fallacy much? Did you read the decision?
Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by Q6T46nT668w6i3m on Wednesday February 15, 2017 @11:20PM (#13657739)
She worked on this technology for years, developing it from it's infancy to in vitro proof. MIT scientists swooped in and within 2 months applied it in-vivo and patented it.

This is wrong.

It's really a shame that Berkeley loses licensing on a tech that was 95% developed at Berkeley.

This is very wrong.

Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight by fny on Wednesday February 15, 2017 @11:38PM (#13657796)
Can you elaborate?